DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data
Version 2 2024-05-30, 15:34
Version 1 2014-10-28, 10:17
journal contribution
posted on 2024-05-30, 15:34 authored by RS McIntyre, M Tohen, Michael BerkMichael Berk, J Zhao, E WeillerDSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data
History
Journal
Journal of Affective DisordersVolume
150Pagination
378-383Location
NetherlandsPublisher DOI
ISSN
0165-0327eISSN
1573-2517Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2013, ElsevierIssue
2Publisher
ELSEVIER SCIENCE BVPublication URL
Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyPsychiatryNeurosciences & NeurologyBipolar I disorderDSM-5 mixed specifierDepressive featuresManic episodeAsenapineOlanzapinePLACEBO-CONTROLLED TRIALBIPOLAR I DISORDERTREATMENTS METAANALYSISSYMPTOMSHYPOMANIAEFFICACY3-WEEK110319 Psychiatry (incl Psychotherapy)920410 Mental HealthInnovation in Mental and Physical Health and Clinical TreatmentSchool of MedicineFaculty of Health111714 Mental Health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC